Related references
Note: Only part of the references are listed.Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems
Holly C. Groom et al.
VACCINE (2022)
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial
Seth Toback et al.
LANCET RESPIRATORY MEDICINE (2022)
Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
Eric Yuk Fai Wan et al.
LANCET INFECTIOUS DISEASES (2022)
Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 Years
Anne M. Hause et al.
PEDIATRICS (2022)
Risk of Appendicitis After mRNA COVID-19 Vaccination in a Danish Population
Helene Kildegaard et al.
JAMA INTERNAL MEDICINE (2022)
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial
Rajeka Lazarus et al.
LANCET (2021)
COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021
Anne M. Hause et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
US Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines
Diane Gubernot et al.
VACCINE (2021)
Association of Facial Paralysis With mRNA COVID-19 Vaccines A Disproportionality Analysis Using the World Health Organization Pharmacovigilance Database
Lucie Renoud et al.
JAMA INTERNAL MEDICINE (2021)
Surveillance for Adverse Events After COVID-19 mRNA Vaccination
Nicola P. Klein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination
Allison L. Naleway et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2021)
The risk of febrile seizures following influenza and 13-valent pneumococcal conjugate vaccines
Meghan Baker et al.
VACCINE (2020)
Determining Which of Several Simultaneously Administered Vaccines Increase Risk of an Adverse Event
Shirley Wang et al.
DRUG SAFETY (2020)
Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11-to 21-Year-Olds
Hung-Fu Tseng et al.
PEDIATRICS (2017)
Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasons
Rongxia Li et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2016)
Demographic characteristics of members of the Vaccine Safety Datalink (VSD): A comparison with the United States population
Lakshmi Sukumaran et al.
VACCINE (2015)
The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety
Michael M. McNeil et al.
VACCINE (2014)
The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: A capture-recapture analysis
Wan-Ting Huang et al.
VACCINE (2012)
Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011
Alison Tse et al.
VACCINE (2012)
The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety
James Baggs et al.
PEDIATRICS (2011)
Real-time vaccine safety surveillance for the early detection of adverse events
Tracy A. Lieu et al.
MEDICAL CARE (2007)
Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland
M Mutsch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2001
WG Zhou et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2004)
Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures
IAW Kotsopoulos et al.
EPILEPSIA (2002)
Share Paper
